GERN logo

Geron Corporation (GERN)

Profile

Full Name

Geron Corporation

Ticker

NASDAQ: GERN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 31, 1996

Indexes

Not included

Website

https://www.geron.com

Employees

229

Key Details

Price

$1.38(+0.36%)

Market cap

$877.27M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$76.99M(+32386.92% YoY)

Annual EPS

-$0.27(+15.62% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.38
    GERN price is $1.38

    30-Day Relative Volume

    1.15
    GERN 30-day relative volume is 1.15

    Price Performance

    Price Today change

    +0.36%
    GERN price is up +0.36% today

    Price YTD change

    -61.16%
    GERN price is down -61.16% since January 1st

    Price 1-year change

    -68.82%
    GERN price is down -68.82% year-on-year

    Price 3-year change

    -48.11%
    GERN price is down -48.11% over the past 3 years

    Price Range

    Price All-time high

    $71.72
    GERN price is currently -98.08% below its historical high of $71.72

    Price 3-year low

    $1.09
    GERN price is currently +26.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $877.27M
    GERN market capitalization is $877.27 million

    Market cap 3-year change

    -12.38%
    GERN market capitalization is down -12.38% over the past 3 years

    Market cap All-time high

    $3.02B
    GERN market capitalization is currently -70.94% below its historical high of $3.02 billion

    Market cap sector rank

    70.86%
    GERN market capitalization is higher than 70.86% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.84%
    GERN shares outstanding is up +5.84% year-on-year

    Shares Outstanding 3-Year Change

    +68.87%
    GERN shares outstanding is up +68.87% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    GERN beta is 1.00

    200-day SMA

    $2.06
    GERN price is currently -33.41% below its 200-day simple moving average

    50-day SMA

    $1.34
    GERN price is currently +2.29% above its 50-day simple moving average

    RSI

    48.48
    GERN 14-day relative strength index is 48.48

    Volume

    1.15
    GERN 30-day relative volume is 1.15

    ATR

    $0.08
    GERN average true range is $0.08

    10-day Historical Volatility

    49.21%
    GERN 10-day historical volatility is 49.21%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $76.99M
    GERN annual revenue is $76.99 million

    Revenue Analysts estimate

    $206.40M
    GERN annual revenue is currently -62.70% lower than the consensus analysts' forecast

    Revenue 1-year change

    +32386.92%
    GERN annual revenue is up +32386.92% year-on-year

    Revenue Sector rank

    66.22%
    GERN annual revenue is higher than 66.22% of companies in Healthcare sector

    EPS

    EPS

    -$0.27
    GERN annual earnings per share is -$0.27

    EPS Analysts estimate

    -$0.11
    GERN annual earnings per share is currently +137.47% higher than the consensus analysts' forecast

    EPS 1-year change

    +15.62%
    GERN annual earnings per share is up +15.62% year-on-year

    EPS Sector rank

    69.41%
    GERN annual earnings per share is higher than 69.41% of companies in Healthcare sector

    Profit

    Gross profit

    $75.74M
    GERN annual gross profit is $75.74 million

    Gross margin

    98.37%
    GERN annual gross profit margin is 98.37%

    Operating profit

    -$173.73M
    GERN annual operating income is -$173.73 million

    Operating margin

    -225.64%
    GERN annual operating profit margin is -225.64%

    Net income

    -$174.57M
    GERN annual net profit is -$174.57 million

    Net margin

    -226.73%
    GERN annual net profit margin is -226.73%

    Expenses

    Total expenses

    $250.73M
    GERN annual total expenses is $250.73 million

    Operating expenses

    $249.47M
    GERN annual total operating expenses is $249.47 million

    Cost of goods sold

    $1.26M
    GERN annual cost of goods sold is $1.26 million

    Selling, general & administrative expenses

    $145.73M
    GERN annual SGA is $145.73 million

    Depreciation and amortization

    $1.22M
    GERN annual depreciation & amortization is $1.22 million

    Interest expense

    $0.00
    GERN annual interest expense is $0.00

    Income tax

    $0.00
    GERN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$156.07M
    GERN annual earnings before interest & taxes is -$156.07 million

    EBITDA

    -$154.85M
    GERN annual EBITDA is -$154.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $594.46M
    GERN annual total assets is $594.46 million

    Non current assets

    $102.79M
    GERN annual long term assets is $102.79 million

    Current assets

    $490.99M
    GERN annual total current assets is $490.99 million

    Cash and cash equivalents

    $79.02M
    GERN annual cash & cash equivalents is $79.02 million

    Accounts receivable

    $35.95M
    GERN annual accounts receivable is $35.95 million

    Inventory

    $38.71M
    GERN annual inventory is $38.71 million

    Liabilities

    Total liabilities

    $314.14M
    GERN annual total liabilities is $314.14 million

    Long term liabilities

    $225.16M
    GERN annual total long term liabilities is $225.16 million

    Current liabilities

    $88.30M
    GERN annual total current liabilities is $88.30 million

    Accounts payable

    $8.60M
    GERN annual accounts payable is $8.60 million

    Debt

    Total debt

    $246.51M
    GERN annual total debt is $246.51 million

    Total debt 1-year change

    +186.98%
    GERN annual total debt is up +186.98% year-on-year

    Long term debt

    $225.16M
    GERN annual long term debt is $225.16 million

    Short term debt

    $21.35M
    GERN annual short term debt is $21.35 million

    Equity & Capital

    Shareholders equity

    $280.32M
    GERN annual stockholders equity is $280.32 million

    Book value

    $280.32M
    GERN annual book value is $280.32 million

    Retained earnings

    -$1.77B
    GERN annual retained earnings is -$1.77 billion

    Working capital

    $402.69M
    GERN annual working capital is $402.69 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$218.62M
    GERN annual cash flow from operations is -$218.62 million

    Cash from operations 1-year change

    -30.33%
    GERN annual cash flow from operations is down -30.33% year-on-year

    Cash from investing

    -$106.00M
    GERN annual cash flow from investing activities is -$106.00 million

    Cash from investing 1-year change

    +41.21%
    GERN annual cash flow from investing activities is up +41.21% year-on-year

    Cash from financing

    $334.37M
    GERN annual cash flow from financing activities is $334.37 million

    Cash from financing 1-year change

    -7.64%
    GERN annual cash flow from financing activities is down -7.64% year-on-year

    CAPEX

    CAPEX

    $680.00K
    GERN annual capital expenditures is $680.00 thousand

    CAPEX 1-year change

    -18.07%
    GERN annual capital expenditures is down -18.07% year-on-year

    Free Cash Flow

    Free cash flow

    -$219.30M
    GERN annual free cash flow is -$219.30 million

    Free cash flow 1-year change

    -30.09%
    GERN annual free cash flow is down -30.09% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.37%
    GERN annual gross profit margin is 98.37%

    Operating margin

    -225.64%
    GERN annual operating profit margin is -225.64%

    Net margin

    -226.73%
    GERN annual net profit margin is -226.73%

    ROA & ROE

    ROA

    -35.32%
    GERN annual return on assets is -35.32%

    ROE

    -66.09%
    GERN annual return on equity is -66.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GERN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GERN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.38
    GERN price to book ratio is 3.38

    PB ratio Sector rank

    68.35%
    GERN price to book ratio is higher than 68.35% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.33
    GERN price to sales ratio is 5.33

    PS ratio Sector rank

    59.43%
    GERN price to sales ratio is higher than 59.43% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.05B
    GERN enterprise value is $1.05 billion

    Enterprise value Sector rank

    74.07%
    GERN enterprise value is higher than 74.07% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -17.97
    GERN EV/EBITDA is -17.97

    EV/EBITDA Sector rank

    7.51%
    GERN EV/EBITDA is higher than 7.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.56
    GERN annual current ratio is 5.56

    Quick ratio

    5.12
    GERN annual quick ratio is 5.12

    Leverage

    Debt to equity

    0.42
    GERN annual debt to equity ratio is 0.42

    Interest coverage ratio

    -
    GERN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    GERN piotroski f-score is 3

    Altman Z-Score

    -2.42
    GERN altman z-score is -2.42

    Analyst ratings

    Recent major analysts updates

    May 8, 25 Scotiabank
    Sector Perform
    Mar 12, 25 Needham
    Buy
    Mar 12, 25 HC Wainwright & Co.
    Neutral
    Feb 27, 25 Stifel
    Buy
    Feb 27, 25 Scotiabank
    Sector Outperform
    Feb 27, 25 Needham
    Buy
    Feb 27, 25 Barclays
    Overweight
    Feb 26, 25 HC Wainwright & Co.
    Neutral
    Feb 18, 25 B. Riley Securities
    Buy
    Jan 13, 25 Needham
    Buy

    Institutional Ownership

    Screeners with GERN included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Geron Corporation?
    • Does Geron Corporation pay dividends?
    • What sector is Geron Corporation in?
    • What industry is Geron Corporation in?
    • What country is Geron Corporation based in?
    • When did Geron Corporation go public?
    • Is Geron Corporation in the S&P 500?
    • Is Geron Corporation in the NASDAQ 100?
    • Is Geron Corporation in the Dow Jones?
    • When was Geron Corporation's last earnings report?
    • When does Geron Corporation report earnings?

    What is the ticker symbol for Geron Corporation?

    The ticker symbol for Geron Corporation is NASDAQ:GERN

    Does Geron Corporation pay dividends?

    No, Geron Corporation does not pay dividends

    What sector is Geron Corporation in?

    Geron Corporation is in the Healthcare sector

    What industry is Geron Corporation in?

    Geron Corporation is in the Biotechnology industry

    What country is Geron Corporation based in?

    Geron Corporation is headquartered in United States

    When did Geron Corporation go public?

    Geron Corporation's initial public offering (IPO) was on July 31, 1996

    Is Geron Corporation in the S&P 500?

    No, Geron Corporation is not included in the S&P 500 index

    Is Geron Corporation in the NASDAQ 100?

    No, Geron Corporation is not included in the NASDAQ 100 index

    Is Geron Corporation in the Dow Jones?

    No, Geron Corporation is not included in the Dow Jones index

    When was Geron Corporation's last earnings report?

    Geron Corporation's most recent earnings report was on August 6, 2025

    When does Geron Corporation report earnings?

    The next expected earnings date for Geron Corporation is November 6, 2025
    On this page